Find My Journal

CX

Chong‐Rui Xu

Guangdong Academy of Medical Sciences CN

0000-0002-3474-2809

279

Publications

7,292

Citations

36

H-Index

69

i10-Index

2.91

2yr Mean Cite

-

Cite/Paper

Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial

Yi‐Long Wu, Caicun Zhou, Chengping Hu, Jifeng Feng, Shun Lü +10 more

The Lancet Oncology 2014

1,966

EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer OA

Zhong‐Yi Dong, Jia‐Tao Zhang, Si‐Yang Maggie Liu, Jian Su, Chao Zhang +8 more

OncoImmunology 2017

437

Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy OA

Y.S. Li, Bo Jiang, Jin‐Ji Yang, X.C. Zhang, Zhou Zhang +20 more

Annals of Oncology 2018

329

HER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung Cancers OA

Bob T. Li, Flavia Michelini, Sandra Misale, Emiliano Cocco, Laura Baldino +44 more

Cancer Discovery 2020

280

Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma OA

Hao Sun, Si‐Yang Maggie Liu, Jiaying Zhou, Jintian Xu, Huang-Kai Zhang +10 more

EBioMedicine 2020

249

Publications

279 total

Osimertinib with or without savolitinib as first-line treatment for MET-aberrant, EGFR-mutant NSCLC: randomized phase 2 trial (FLOWERS)

Anna Li, W. Feng, Juan Li, Bing Xu, Jun Zhao - Nature Communications, 2026

Cited by 1 Semantic Scholar

Multiple Primary Lung Cancer With Driver Gene Mutations: Is Targeted Therapy Always the Optimal Choice?—A Case Report

Zi-Rui Ren, Lv Wu, Chang Lu, Fen Wang, Ying-Long Peng - Thoracic Cancer, 2026

Cited by 0 Semantic Scholar

PP01.42: Efficacy and Multi-omics Insights of Immune Checkpoint Inhibitors in NSCLC with Leptomeningeal Metastasis

Li-Bo Tang, Yang-Si Li, Chongrui Xu, K. Yin, Hui-Bing Gao - Journal of Thoracic Oncology, 2026

Cited by 0 Semantic Scholar

PP01.54: The Outcome of Pemigatinib in Advanced NSCLC With A Novel FGFR Fusion: Case Report

Qian Huang, Li-Bo Tang, Lv Wu, Yu Deng, Zhi-hong Chen - Journal of Thoracic Oncology, 2026

Cited by 0 Semantic Scholar

PP01.01: Association and Prognosis of Non-Cancerous Respiratory Diseases to Lung Cancer and Pan-Cancer: Observational and Mendelian Randomization Analysis

Ying-Long Peng, Jia-ting Li, Lv Wu, Hong-Yi Zhu, Zi-Rui Ren - Journal of Thoracic Oncology, 2026

Cited by 0 Semantic Scholar

Rechallenge with immune-checkpoint inhibitors in patients with advanced-stage lung cancer

Li-Bo Tang, Ying-Long Peng, Ji Chen, Jia-ting Li, M. Zheng - Nature Reviews Clinical Oncology, 2025

Cited by 18 Semantic Scholar

Causal relationship between oral/gut microbiota and lung cancer: a two-sample Mendelian randomization study

Zi-Jian Huang, Lv Wu, Ying-Long Peng, Zhi-hong Chen, Chongrui Xu - Discover Oncology, 2025

Cited by 1 Semantic Scholar

Letter Regarding "Revolutionizing NSCLC Treatment: Unleashing the Potential of IBI351 and Its Critical Care Impact".

Chongrui Xu, Jia-Xin Lin, Qing Zhou, Yi-Long Wu - Journal of Thoracic Oncology, 2025

Cited by 0 Semantic Scholar

Clinical and dynamic circulating cytokines profile features of long-term progression-free survival benefit to immune checkpoint inhibitors in advanced non–small cell lung cancer OA

Jia-Yi Deng, M. Gao, Xue Fan, Hong-Hong Yan, Wei-Chi Luo - Cancer Immunology and Immunotherapy, 2025

Cited by 2 Semantic Scholar

Multiple ctDNA- based biomarkers predict benefit from selective RET Inhibition in non-small cell lung cancer patients: exploratory analysis of a prospective study

Chang Lu, Chongrui Xu, Yi-chen Zhang, E. Ke, Yue-Li Sun - Biomarker Research, 2025

Cited by 0 Semantic Scholar

Research Topics

Lung Cancer Treatments and Mutations (179) Lung Cancer Research Studies (67) Colorectal Cancer Treatments and Studies (46) Cancer Genomics and Diagnostics (46) Cancer Immunotherapy and Biomarkers (39)

Frequent Co-Authors

YI

Yi‐Long Wu

13 joint publications

QI

Qing Zhou

11 joint publications

WE

Wen‐Zhao Zhong

11 joint publications

JI

Jian Su

9 joint publications

HA

Hai‐Yan Tu

8 joint publications

JI

Jin‐Ji Yang

8 joint publications

Affiliations

Ningbo University

CN 2025 - 2025

Tongji University

CN 2024 - 2011

University of Sydney

AU 2020 - 2018

Union Hospital

CN 2006 - 2006

Memorial Sloan Kettering Cancer Center

US 2022 - 2018

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers